Gregory Berk

Insider Reports History

Reporting-owner location: San Francisco, CA
Latest reporting-owner signature: /s/ Gregory Berk, M.D.
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gregory Berk

Form 4 holding Pres. of R&D, CMO

GT Biopharma, Inc.

Security class: Option to purchase Common Stock
Shares / value: 50,000
Estimated value
Report date: 15 Jul 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Gregory Berk

4 GTBP

GT Biopharma, Inc.

Report period: 15 Jul 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 Jul 2022, 21:44
Role: Pres. of R&D, CMO
Next action: Open filing details

4 GTBP

GT Biopharma, Inc.

Report period: 16 Feb 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 14 Feb 2022, 16:10
Role: Director
Next action: Open filing details

3 GTBP

GT Biopharma, Inc.

Report period: 11 Nov 2020
Transactions: 0
Transaction value: $0
Accepted by SEC: 14 Feb 2022, 15:06
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .